ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Spyre Therapeutics at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Spyre Therapeutics brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2933-CT. Its program centres on TL1A as a target in rheumatoid arthritis, comparing anti-TL1A with anti-TNF in a mouse model and tracing TL1A signaling in the joint lining.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Spyre Therapeutics Waltham, MA | |
A clinical-stage biotechnology company developing therapies for inflammatory diseases. | Booth Exhibiting at Booth 2933-CT Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Spyre Therapeutics
Tell us what you sell and we’ll find the people at Spyre Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction